The future of telemedicine and its reimbursement

Patient demand for telemedicine will remain after the COVID-19 pandemic, and as a result more payers will reimburse for it

David Zetter, founder of Zetter HealthCare LLC, says patient demand for telemedicine will remain after the COVID-19 pandemic, and as a result more payers will reimburse for it.

Related Videos
Claire Ernst, JD, gives expert advice
Arien Malec
remote patient monitoring
COVID-19
referral
Michael Joyce gives expert advice
Michael Joyce, CFP, CFA, President of Agili, gives expert advice
no shows
Related Content
© 2023 MJH Life Sciences

All rights reserved.